Currently in the US, one in five Americans will develop skin cancer. More than 5.4 million new skin cancers are now diagnosed per year, more than the collective incidence of breast, colon, prostate, and lung cancers. Over the past three decades, more people have been diagnosed with skin cancer than all other cancers combined. About 90% of nonmelanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun, and topical sunscreens alone are not the answer. Chemical sunscreens pose several potential health and environmental risks, and mineral sunscreens do not block visible light, which can also cause skin damage. Furthermore, most people are not vigilant enough to apply sunscreen daily.
Drs. Warner and Strow spent a year studying oral ingredients with proven photoprotective effects based on strict scientific research. After the 2015 publication of an article in the New England Journal of Medicine revealing that nicotinamide, a form of vitamin B3, can decrease the risk of new skin cancers and precancers in high risk patients, Drs. Strow and Warner formulated this ingredient with Polypodium leukotomos, an extract shown to help protect skin from UV sun damage. They combined these two powerful ingredients, and SolShield™ was born.